Tumor suppression by the prohibitin gene 3′untranslated region RNA in human breast cancer

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5251-5256

  Manjeshwar, Sharmila ^a   Branam, Dannielle E ^a   Lerner, Megan R ^a,b   Brackett, Daniel J ^a,b   Jupe, Eldon R ^a,b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c InterGenetics Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROHIBITIN; RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

3' UNTRANSLATED REGION; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; COLONY FORMATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROHIBITIN GENE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

3' UNTRANSLATED REGIONS; ALLELES; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, NUDE; PROTEIN BIOSYNTHESIS; PROTEINS; REPRESSOR PROTEINS; RNA, NEOPLASM; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0141816859     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. McClung, J. K., Danner, D. B., Stewart, D. A., Smith, J. R., Schneider, E. L., Lumpkin, C. K., Dell'Orco, R. T., and Nucll, M. J. Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem. Biophys. Res. Commun., 164: 1316-1322, 1989.
2. Nuell, M. J., Stewart, D. A., Walker, L., Friedman, V., Wood, C. M., Owens, G. A., Smith, J. R., Schneider, E. L., Dell'Orco, R. T., Lumpkin, C. K., Danner, D. B., and McClung, J. K. Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell. Biol., 11: 1372-1381, 1991.
3. Ikonen, E., Fiedler, K., Parton, R. G., and Simons, K. Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Lett., 358: 273-277, 1995.
4. Snedden, W. A., and Fromm, H. Characterization of the plant homologue of prohibitin, a gene associated with antiproliferative activity in mammalian cells. Plant Mol. Biol., 33: 753-756, 1997.
5. McClung, J. K., Jupe, E. R., Liu, X-T., and Dell'Orco, R. T. Prohibitin: potential role in senescence, development and tumor suppression. Exp. Gerontol., 30: 99-124, 1995.
6. Jazwinski, S. M. Longevity, genes and aging. Science (Wash. DC), 273: 54-59, 1996.
7. Coates, P. J., Jamieson, D. J., Smart, K., Prescott, A. R., and Hall, P. A. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol., 7: R607-R610, 1997.
8. Eveleth, D. D. Jr., and Marsh, J. L. Sequence and expression of the Cc gene, a member of the dopa decarboxylase gene cluster of Drosophila: Possible translational regulation. Nucleic Acids Res., 14: 6169-6183, 1986.
9. Thompson, W. E., Sanbuissho, A., Lee, G. Y., and Anderson, E. Steroidogenic acute regulatory (StAR) protein (p25) and prohibitin (p28) from cultured rat ovarian granulosa cells. J. Reprod. Fertility, 109: 337-348, 1997.
10. Welburn, S. C., and Murphy, N. B. Prohibitin and RACK homologues are upregulated in trypanosomes induced to undergo apoptosis and in naturally occurring terminally differentiated forms. Cell Death Differentiation, 5: 615-622, 1998.
11. Narasimhan, S., Armstrong, M., McClung, J. K., Richards, F. F., and Spicer, E. K. Prohibitin, a putative negative control element present in Pneumocystis carinii. Infect. Immun., 65: 5125-5130, 1997.
12. Wang, S., Nath, N., Adlam, M., and Chellappan, S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene, 18: 3501-3510, 1999.
13. Wang, S., Nath, N., Fusaro, G., and Chellappan, S. Rb and Prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol. Cell. Biol., 19: 7447-7460, 1999.
14. White, J. J., Ledbetter, D. H., Eddy, R. L., Jr., Shows, T. B., Stewart, D. A., Nuell, M. J., Friedman, V., Wood, C. M., Owens, G. A., McClung, J., Danner, D. B., and Morton, C. C. Assignment of the human prohibitin gene(PHB) to chromosome 17 and identification of DNA polymorphism. Genomics, 11: 228-230, 1991.
15. Black, D. M., Nicolai, H., Borrow, J., and Solomon, E. A somatic cell hybrid map of the long arm of human chromosome 17, containing the familial breast cancer locus (BRCA1). Am. J. Hum. Genet., 52: 702-710, 1993.
16. Nagai, M. A., Yamamoto, L., Salaorni, S., Pacheco, M. M., Bretani, M. M., Barbosa, E. M., Brentani, R. R., Mazoyer, S., Smith, S. A., Ponder, B. A. J., and Mulligan, L. M. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumors. Genes Chromosomes Cancer, 11: 58-62, 1994.
17. Sato, T., Saito, H., Swensen, J., Olifant, a., Wood, C., Danner, D., Sakamoto, T., Takita, K., Kasumi, F., Miki, Y., Skolnick, M., and Nakamura, Y. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res., 52: 1643-1646, 1992.
18. Tokino, T., Davidson, N., Helzlsouer, K., Zehnbauer, B., Nakamura, Y., Vogelstein, B., and Sidransky, D. Absence of germline prohibitin mutations in early onset breast cancer. Int. J. Oncol., 3: 769-722, 1993.
19. Sato, T., Sakamoto, T., Takita, K-I., Saito, H., Okui, K., and Nakamura, Y. The human prohibitin (PHB) gene family and its somatic mutations in human tumors. Genomics, 17: 762-764, 1993.
20. Cliby, W., Sarkar, G., Ritland, S. R., Hartmann, L., Podratz, K. C., and Jenkins, R. B. Absence of prohibitin gene mutations in human epithelial ovarian tumors. Gynecol. Oncol., 50: 34-37, 1994.
21. Asamoto, M., and Cohen, S. M. Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines. Cancer Lett., 83: 201-207, 1994.
22. Jupe, E., Liu, X-T., Kiehlbauch, J. L., McClung, J. K., and Dell'Orco, R. T. Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines. Exp. Cell Res., 218: 577-580, 1995.
23. Jupe, E., Liu, X-T., Kiehlbauch, J. L., McClung, J. K., and Dell'Orco, R. T. The 3′untranslated region of prohibitin and cellular immortalization. Exp. Cell Res., 224: 128-135, 1996.
24. Jupe, E. R., Liu, X-T., Kiehlbauch, J. L., McClung, J. K., and Dell'Orco, R. T. Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′untranslated region mutations. Cell Growth Differ., 7: 871-878, 1996.
25. Jupe, E. R., Badgett, A. A., Neas, B. R., Craft, M. A., Mitchell, D. S., Resta, R., Mulvihill, J. J., Aston, C. E., and Thompson, L. F. Single nucleotide polymorphism in prohibitin 3′untranslated region and breast cancer susceptibility. Lancet, 357: 1588-1589, 2001.
26. Rastinejad, F., and Blau, H. M. Genetic complementation reveals a novel regulatory role for 3′untranslated regions in growth and differentiation. Cell, 72: 1107-1117, 1993.
27. Rastinejad, F., Conboy, M. J., Rando, T. A., and Blau, H. M. Tumor suppression by RNA from the 3′untranslated region of α-tropomyosin. Cell, 75: 1107-1117, 1993.
28. Fan, H., Villegas, C., Huang, A., and Wright, J. A. Suppression of malignancy by the 3′untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs. Cancer Res., 56: 4366-4369, 1996.
29. Fan, H., Huang, A., Villegas, C., and Wright, J. A. The R1 component of mammalian ribonucleotide reductase has malignancy suppressing activity as demonstrated by gene transfer experiments. Proc. Natl. Acad. Sci. USA, 94: 13181-13186, 1997.
30. 1/S transit specifically. J. Cell Biol., 122: 461-471, 1993.
31. van Slooten, H. J., Bonsing, B. A., Hiller, A. J., Colbern, G. T., van Dierendonck, J. H., Cornelisse, C. J., and Smith, H. S. Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer. Br. J. Cancer, 72: 22-30, 1995.
32. Fanjul, A. N., Delia, D., Pierotti, M. A., Rideout, D., Yu, J. Q., Pfahl, M., and Qiu, J. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem., 271: 22441-22446, 1996.
33. Martinez, E. J., Owa, T., Schreiber, S. L., and Corey, E. J. Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ccteinascidin 743. Proc. Natl. Acad. Sci. USA, 96: 3496-3501, 1999.
34. Pianetti, S., Guo, S., Kavanagh, K. T., and Sonenshein, G. E. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res., 62: 652-655, 2002.
35. Davis. S., and Watson, J. C. In vitro activation of the interferon-induced, double stranded RNA dependent protein kinase PKR by RNA from the 3κuntranslated regions of human α-tropomyosin. Proc. Natl. Acad. Sci., 93: 508-513, 1996.
36. Lee, R. C., Feinbaum, R. L., and Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with anti-sense complementarity to lin-14. Cell, 75: 843-854, 1993.
37. Rishi, A. K., Hsu, C. K. A., Li, X-S., Hussain, A., Gerald, T., and Fontana, J. Transcriptional repression of the cyclin dependent kinase inhibitor p21 WAF1/CIP1 gene mediated by cis elements present in the 3′untranslated region. Cancer Res., 57: 5129-5136, 1997.
38. Ishizaki, J., Nevins, J. R., and Sullenger, B. A. Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function. Nat. Med., 2: 1386-1389, 1996.
39. Jupe, E. R., Lerner, M., Thompson, L., Branam, D., Manjeshwar, S., Farmer, D. Taylor, B., Hollingsworth, A., and Brackett, D. Prohibitin RNA therapy in a metastatic rat mammary tumor model. Mol. Ther., 1: S162-S163, 2000.